The FDA created the Expedited Access Pathway program last year to facilitate the development and access of new medical technology for patients suffering from life-threatening illnesses.
Supply Chain
Salutaris Medical Devices is one of the top 10 finalists for the spring 2016 round of the Arizona Innovation Challenge, a competitive grant program sponsored by the Arizona Commerce Authority, according to Arizona Daily Star.
Medical device company OtoNexus is developing and commercializing a device that uses Doppler ultrasound to provide more accurate diagnoses of middle ear infections.
On Wednesday, Florida health officials changed the state's policy for administering expensive hepatitis C drugs to Medicaid patients, now requiring insurance companies to provide the drug at an earlier stage of the disease.
On Wednesday, North Carolina Governor Pat McCrory (R) signed an application that seeks a waiver from the government to allow changes to the state's $14 billion health insurance program for the poor and disabled.
Yesterday, the U.S. Food and Drug Administration approved the first blood-based genetic test that can detect gene mutations in non-small cell lung cancer patients.
Hudson, Wis.-based injection molder Phillips-Medisize will expand its drug delivery operations with the acquisition of Medicom Innovation Partner, the companies announced on June 1st.
With drug prices on the rise, more and more drugs will be deemed ineligible for reimbursement, challenging drug developers to provide evidence of clinical superiority.
India-based drug manufacturer Aurobindo Pharma plans to focus on increased Abbreviated New Drug Application filings and new differentiated product launches in the United States to maintain its growth.
Massachusetts' Democratic lawmakers will vote on a bill to hold pharmaceutical companies more accountable for their pricing information.